5-134607038-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 4P and 3B. PM1PM2BP4_ModerateBP6
The NM_016103.4(SAR1B):c.509C>T(p.Ala170Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in Lovd as Likely benign (no stars).
Frequency
Consequence
NM_016103.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAR1B | NM_016103.4 | c.509C>T | p.Ala170Val | missense_variant | 7/7 | ENST00000402673.7 | NP_057187.1 | |
SAR1B | NM_001033503.3 | c.509C>T | p.Ala170Val | missense_variant | 8/8 | NP_001028675.1 | ||
SAR1B | XM_047417257.1 | c.509C>T | p.Ala170Val | missense_variant | 7/7 | XP_047273213.1 | ||
SAR1B | XM_047417258.1 | c.305C>T | p.Ala102Val | missense_variant | 5/5 | XP_047273214.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAR1B | ENST00000402673.7 | c.509C>T | p.Ala170Val | missense_variant | 7/7 | 1 | NM_016103.4 | ENSP00000385432.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461422Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727050
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.509C>T (p.A170V) alteration is located in exon 8 (coding exon 6) of the SAR1B gene. This alteration results from a C to T substitution at nucleotide position 509, causing the alanine (A) at amino acid position 170 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at